Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adding HPV16 testing to abnormal cervical smear detection is useful for predicting CIN3: a prospective study.

Hidenori Tanaka1, Hirokazu Sato, Naoki Sato

  • 1Department of Obstetrics and Gynecology, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan. tanakah@obgyn.med.akita-u.ac.jp

Acta Obstetricia Et Gynecologica Scandinavica
|April 3, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Programmed cell death ligand 1 (PD-L1) inhibition in tumor naïve mice is bone-sparing throughout the lifespan.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study).

Rheumatology and therapy·2026
Same author

Fluorescence-Guided Detection of Perineural and Bony Invasion With Margin Correlation in Gingival Squamous Cell Carcinoma Using Panitumumab-IRDye800.

Head & neck·2026
Same author

EGFR S442 ectodomain mutation confers cetuximab resistance that can be overcome by ERBB2 blockade with trastuzumab-deruxtecan.

Cancer letters·2026
Same author

Total Chemical Synthesis of the Human Milk Oligosaccharide Disialyllacto-<i>N</i>-tetraose and Its Degradation by <i>Bifidobacterium bifidum</i> Sialidases.

Organic letters·2026
Same author

Increased Extracolonic Cancer Incidence and Mortality in Patients with Serrated Polyposis Syndrome with a History of Colorectal Cancer: A Comparative Cohort Study.

Digestion·2026

Adding human papillomavirus 16 (HPV16) testing to abnormal cervical smears significantly improves the prediction of cervical intraepithelial neoplasia 3 (CIN3). Persistent HPV16 infection strongly indicates a higher risk of progression to CIN3.

Area of Science:

  • Gynecologic Oncology
  • Virology
  • Diagnostic Medicine

Background:

  • Cervical cancer screening relies on detecting abnormalities in cervical smears.
  • Human papillomavirus 16 (HPV16) is a high-risk oncogenic virus implicated in cervical cancer development.
  • The utility of HPV16 testing in predicting high-grade cervical lesions requires further investigation.

Purpose of the Study:

  • To evaluate the effectiveness of incorporating HPV16 testing into the management of abnormal cervical smears.
  • To determine if HPV16 testing can predict the progression to cervical intraepithelial neoplasia 3 (CIN3).

Main Methods:

  • A prospective study followed 153 patients with abnormal cervical smears (CIN1,2 or ASCUS) from 1994-2001.
  • Cytology and HPV16 testing via nested PCR were performed at the initial visit.

Related Experiment Videos

  • Patients with positive HPV16 tests were monitored more frequently for persistent infection and progression to CIN3.

    • Main Results:

    • Four out of 16 (25%) HPV16-positive patients progressed to CIN3, all with persistent HPV16 infection.
    • Only three out of 137 (2.2%) HPV16-negative patients progressed to CIN3.
    • The odds ratio for progression to CIN3 in the HPV16-positive group was 14.9.

    Conclusions:

    • HPV16 testing significantly increases the predictive value for CIN3 in patients with abnormal cervical smears.
    • Persistent HPV16 infection is a key indicator of increased risk for CIN3 progression.
    • Integrating HPV16 testing into cervical smear analysis offers a valuable tool for early detection and management of CIN3.